Literature DB >> 5096517

Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism.

R M Blaese, W Strober, A L Levy, T A Waldmann.   

Abstract

The Wiskott-Aldrich syndrome is an immune deficiency disorder with an impairment of both humoral and cellular immune responses. Metabolic turnover studies of IgG, IgA, IgM, and albumin were conducted in seven patients with the Wiskott-Aldrich syndrome using purified radioiodinated proteins. The survival of each of the proteins studied was significantly shortened with a half-time of 7.5 days for IgG (normal 22.9 +/-4 SD), 3.0 days for IgA (normal 5.8 +/-1), 5.0 days for IgM (normal 10.1 +/-2.1), and 8.6 days for albumin (normal 17, range 13-20); the fractional catabolic rates were correspondingly elevated and the distribution of protein among the body compartments was normal. For three of the four proteins. IgG, IgA, and albumin, the steady-state synthetic rates were generally elevated leading to normal or even elevated serum proteins levels. Thus, in the case of IgA, the synthetic rate averaged five times normal while the fractional degradative rate was twice normal. The resulting serum concentration was, therefore, significantly elevated, IgM represented an exception to this pattern in that the increased rate of degradation was not counterbalanced by an increased synthetic rate and, therefore, the serum levels were low. Albumin clearance studies using albumin-(51)Cr showed gastrointestinal protein loss in these patients to be slightly greater than normal, but this could account for only a small fraction of the hypercatabolism observed. There was no proteinuria or abnormalities of thyroid, adrenal, renal, or liver function. Thus, none of the previously recognized causes of increased serum protein catabolism were present. Patients with the Wiskott-Aldrich syndrome, therefore, have a unique disorder of serum protein metabolism characterized by endogenous hypercatabolism of at least four major serum proteins. This phenomenon may be related to reticuloendothelial hyperfunction since the Wiskott-Aldrich syndrome is associated with reticuloendothelial hyperplasia and accelerated clearance of colloidal materials from the plasma.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5096517      PMCID: PMC292175          DOI: 10.1172/JCI106731

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Wiskott-Aldrich syndrome: clinical, immunologic, and pathologic observations.

Authors:  J A Wolff
Journal:  J Pediatr       Date:  1967-02       Impact factor: 4.406

2.  Paraproteinaemia and unusual dys-gamma-globulinaemia in a case of Wiskott-Aldrich syndrome. An immunochemical study.

Authors:  J Rádl; J Masopust; J Houstĕk; O Hrodek
Journal:  Arch Dis Child       Date:  1967-12       Impact factor: 3.791

3.  Immunoglobulin metabolism in ataxia telangiectasia.

Authors:  W Strober; R D Wochner; M H Barlow; D E McFarlin; T A Waldmann
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

4.  Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity.

Authors:  M D Cooper; H P Chae; J T Lowman; W Krivit; R A Good
Journal:  Am J Med       Date:  1968-04       Impact factor: 4.965

5.  The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition.

Authors:  R M Blaese; W Strober; R S Brown; T A Waldmann
Journal:  Lancet       Date:  1968-05-18       Impact factor: 79.321

6.  Serum levels of immune globulins in health and disease: a survey.

Authors:  E R Stiehm; H H Fudenberg
Journal:  Pediatrics       Date:  1966-05       Impact factor: 7.124

7.  Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism.

Authors:  R D Wochner; G Drews; W Strober; T A Waldmann
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

8.  The development of malignancy in the course of the Aldrich syndrome.

Authors:  R W ten Bensel; E M Stadlan; W Krivit
Journal:  J Pediatr       Date:  1966-05       Impact factor: 4.406

9.  Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection.

Authors:  W Strober; R D Wochner; P P Carbone; T A Waldmann
Journal:  J Clin Invest       Date:  1967-10       Impact factor: 14.808

10.  Reticuloendothelial system phagocytic function in patients with Hodgkin's disease.

Authors:  J N Sheagren; J B Block; S M Wolff
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

View more
  18 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.

Authors:  M Shimizu; N P Nikolov; K Ueno; K Ohta; R M Siegel; A Yachie; F Candotti
Journal:  Clin Immunol       Date:  2011-10-19       Impact factor: 3.969

3.  Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin.

Authors:  T A Waldmann; W D Terry
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

4.  [The regulation of serum albumin in physiological and pathological conditions (author's transl)].

Authors:  K Weigand
Journal:  Klin Wochenschr       Date:  1977-04-01

Review 5.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Springer Semin Immunopathol       Date:  1998

6.  Immunoglobulins and transient paraproteins in sera of patients with the Wiskott-Aldrich syndrome: a follow-up study.

Authors:  J Radl; L H Dooren; A Morell; F Skvaril; J M Vossen; C H Uittenbogaart
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

7.  Monoclonal Gammopathy of Unclear Significance in a Child with Wiskott-Aldrich Syndrome: a Rare Occurrence.

Authors:  Rashmi Rikhi; Sagar Bhattad; Ankur Jindal; Biman Saikia; Ravinder Garg; Amit Rawat; Deepti Suri; Surjit Singh
Journal:  J Clin Immunol       Date:  2019-01-03       Impact factor: 8.317

8.  Serum monoclonal immunoglobulins in childhood.

Authors:  F Danon; M Seligmann
Journal:  Arch Dis Child       Date:  1973-03       Impact factor: 3.791

9.  Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.

Authors:  L C Altman; R Snyderman; R M Blaese
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

Review 10.  The synthesis and degradation of liver-produced proteins.

Authors:  A S Tavill
Journal:  Gut       Date:  1972-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.